Last reviewed · How we verify

A Randomized, Double-blind, Triple-dummy, Placebo Controlled, Single-dose, 4-way Crossover Study To Determine The Relative Abuse Potential Of Pf-00345439 (Oxycodone Extended Release Capsules) Compared To Immediate-release Oxycodone And Placebo When Administered Orally Whole And/or Chewed To Non-dependent, Recreational Opioid Users Under Fasted Conditions

NCT01986283 Phase 1 COMPLETED

This study will determine the relative abuse potential of intact and chewed PF-00345439 (Oxycodone Extended-Release Capsules) compared to crushed oxycodone HCL immediate release (IR) tablets and placebo administered orally to non-dependent, recreational opioid users.

Details

Lead sponsorPain Therapeutics
PhasePhase 1
StatusCOMPLETED
Enrolment67
Start date2013-11
Completion2014-08

Conditions

Interventions

Primary outcomes

Countries

United States